Evaluation of biomarkers in multifocal/multicentric invasive breast carcinomas

International Journal of Surgical Pathology

Volumn 21, Issue 2, 2013, Pages 126-132

  Pekmezci, Melike ^a   Szpaderska, Anna ^b   Osipo, Clodia ^b   Erşahin, Çaǧatay ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

breast carcinoma; estrogen receptor; HER2; hormone receptor; multicentric; multifocal; progesterone receptor; roliferation index

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; BREAST CARCINOMA; CANCER GRADING; CLINICAL EVALUATION; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MULTIPLE CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVIEW; BIOSYNTHESIS; BREAST TUMOR; CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROCEDURES;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM GRADING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84875698915     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896912467370     Document Type: Review

References (23)

1. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 ; 11: 155-168
2. Viale G, Regan MM, Maiorano E, et al. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98. J Clin Oncol. 2007 ; 25: 3846-3852
3. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998 ; 351: 1451-1467
4. Mohsin SK, Weiss H, Havighurst T, et al. Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol. 2004 ; 17: 1545-1554
5. Stendahl M, Ryden L, Nordenskjold B, Jonsson PE, Landberg G, Jirstrom K. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clin Cancer Res. 2006 ; 12: 4614-4618
6. Paik S, Hazan R, Fisher ER, et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol. 1990 ; 8: 103-112
7. Press MF, Bernstein L, Thomas PA, et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997 ; 15: 2894-2904
8. De Laurentiis M, Arpino G, Massarelli E, et al. A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. Clin Cancer Res. 2005 ; 11: 4741-4748
9. Vogel CL, Cobleigh MA, Tripathy D, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002 ; 20: 719-726
10. Dawson PJ, Baekey PA, Clark RA. Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol. 1995 ; 26: 965-969
11. Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2002 ; 94: 1910-1916
12. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007 ; 25: 118-145
13. Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010 ; 134: e48 - e72
14. Fisher ER, Gregorio R, Redmond C, Vellios F, Sommers SC, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4): I. Observations concerning the multicentricity of mammary cancer. Cancer. 1975 ; 35: 247-254
15. Sarnelli R, Squartini F. Multicentricity in breast cancer: a submacroscopic study. Pathol Annu. 1986 ; 21 (pt 1). 143-158
16. Anastassiades O, Iakovou E, Stavridou N, Gogas J, Karameris A. Multicentricity in breast cancer. a study of 366 cases. Am J Clin Pathol. 1993 ; 99: 238-243
17. Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. Pathol Annu. 1981 ; 16 (pt 2). 83-102
18. Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001 ; 50: 735-742
19. Teixeira MR, Pandis N, Bardi G, et al. Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br J Cancer. 1994 ; 70: 922-927
20. Tsuda H, Hirohashi S. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q. Cancer Res. 1995 ; 55: 3395-3398
21. Teixeira MR, Ribeiro FR, Torres L, et al. Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer. 2004 ; 91: 775-782
22. Eeles R, Knee G, Jhavar S, et al. Multicentric breast cancer: clonality and prognostic studies. Breast Cancer Res Treat. 2011 ; 129: 703-716
23. Choi Y, Kim EJ, Seol H, et al. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. Hum Pathol. 2012 ; 43: 48-55